Tendon Anchor
Smith & Nephew, Inc. · Decision date Oct 27, 2026
What did the FDA decide?
FDA recorded a substantial equivalence decision dated October 27, 2026 for K263461, a Tendon Anchor submitted by Smith & Nephew, Inc. of Andover, Massachusetts. The submission was received September 28, 2026, and the public record lists the medical specialty as General and Plastic Surgery under product code GDW. A substantial equivalence determination is a 510(k) clearance, not premarket approval of a new device.
The FDA document states the intended use as fixation of the REGENETEN Bioinductive Implant to soft tissues, which places the anchor as a fixation component used with that implant rather than as a standalone therapeutic device. The record does not describe the anchor's materials, dimensions, or any design change relative to a predicate, and no predicate device number appears in the available excerpts. Clinical performance data and labeling details are likewise not included in the source material reviewed.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Oct 27, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K263461
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Smith & Nephew, Inc.
- Product code
- GDW
- Decision code
- SESE
- Decision date
- Oct 27, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Staple, Implantable.
- Applicant
- Smith & Nephew, Inc.
- Product code
- GDW
- FDA device class
- 2
FDA decision timeline
K263461 received
Application receipt date recorded by FDA.
K263461 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code GDW
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Ezisurg Medical Co., Ltd. | 510(k) clearance | Sep 25, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Smith & Nephew, Inc.
- Headquarters
- Not reported
- Brand website
- smith-nephew.com
- FDA applicant address
- Andover, MA
Sources and methodology
- Original FDA record: K263461
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records